img

Global Muscarinic Acetylcholine Receptor Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Muscarinic Acetylcholine Receptor Market Research Report 2024

Muscarinic Acetylcholine Receptor (m-g protein coupled Receptor) is an autoantibody in the serum of patients with myasthenia gravis.
According to Mr Accuracy reports’s new survey, global Muscarinic Acetylcholine Receptor market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Muscarinic Acetylcholine Receptor market research.
Key companies engaged in the Muscarinic Acetylcholine Receptor industry include Anavex Life Sciences Corp, AstraZeneca Plc, Heptares Therapeutics Ltd, Karuna Pharmaceuticals Inc, NeuroHealing Pharmaceuticals Inc and Sumitomo Dainippon Pharma Co Ltd, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Muscarinic Acetylcholine Receptor were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Muscarinic Acetylcholine Receptor market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Muscarinic Acetylcholine Receptor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Anavex Life Sciences Corp
AstraZeneca Plc
Heptares Therapeutics Ltd
Karuna Pharmaceuticals Inc
NeuroHealing Pharmaceuticals Inc
Sumitomo Dainippon Pharma Co Ltd
Segment by Type
M1
M4
M5
Others

Segment by Application


Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Muscarinic Acetylcholine Receptor report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muscarinic Acetylcholine Receptor Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 M1
1.2.3 M4
1.2.4 M5
1.2.5 Others
1.3 Market by Application
1.3.1 Global Muscarinic Acetylcholine Receptor Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Attention Deficit Hyperactivity Disorder
1.3.3 Psychiatric Disorders
1.3.4 Alzheimer's Disease
1.3.5 Chronic Obstructive Pulmonary Disease
1.3.6 Memory Impairment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Muscarinic Acetylcholine Receptor Market Perspective (2018-2034)
2.2 Muscarinic Acetylcholine Receptor Growth Trends by Region
2.2.1 Global Muscarinic Acetylcholine Receptor Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Muscarinic Acetylcholine Receptor Historic Market Size by Region (2018-2024)
2.2.3 Muscarinic Acetylcholine Receptor Forecasted Market Size by Region (2024-2034)
2.3 Muscarinic Acetylcholine Receptor Market Dynamics
2.3.1 Muscarinic Acetylcholine Receptor Industry Trends
2.3.2 Muscarinic Acetylcholine Receptor Market Drivers
2.3.3 Muscarinic Acetylcholine Receptor Market Challenges
2.3.4 Muscarinic Acetylcholine Receptor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Muscarinic Acetylcholine Receptor Players by Revenue
3.1.1 Global Top Muscarinic Acetylcholine Receptor Players by Revenue (2018-2024)
3.1.2 Global Muscarinic Acetylcholine Receptor Revenue Market Share by Players (2018-2024)
3.2 Global Muscarinic Acetylcholine Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Muscarinic Acetylcholine Receptor Revenue
3.4 Global Muscarinic Acetylcholine Receptor Market Concentration Ratio
3.4.1 Global Muscarinic Acetylcholine Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muscarinic Acetylcholine Receptor Revenue in 2022
3.5 Muscarinic Acetylcholine Receptor Key Players Head office and Area Served
3.6 Key Players Muscarinic Acetylcholine Receptor Product Solution and Service
3.7 Date of Enter into Muscarinic Acetylcholine Receptor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Muscarinic Acetylcholine Receptor Breakdown Data by Type
4.1 Global Muscarinic Acetylcholine Receptor Historic Market Size by Type (2018-2024)
4.2 Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Type (2024-2034)
5 Muscarinic Acetylcholine Receptor Breakdown Data by Application
5.1 Global Muscarinic Acetylcholine Receptor Historic Market Size by Application (2018-2024)
5.2 Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Muscarinic Acetylcholine Receptor Market Size (2018-2034)
6.2 North America Muscarinic Acetylcholine Receptor Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Muscarinic Acetylcholine Receptor Market Size by Country (2018-2024)
6.4 North America Muscarinic Acetylcholine Receptor Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Muscarinic Acetylcholine Receptor Market Size (2018-2034)
7.2 Europe Muscarinic Acetylcholine Receptor Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Muscarinic Acetylcholine Receptor Market Size by Country (2018-2024)
7.4 Europe Muscarinic Acetylcholine Receptor Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size (2018-2034)
8.2 Asia-Pacific Muscarinic Acetylcholine Receptor Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region (2018-2024)
8.4 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Muscarinic Acetylcholine Receptor Market Size (2018-2034)
9.2 Latin America Muscarinic Acetylcholine Receptor Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Muscarinic Acetylcholine Receptor Market Size by Country (2018-2024)
9.4 Latin America Muscarinic Acetylcholine Receptor Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size (2018-2034)
10.2 Middle East & Africa Muscarinic Acetylcholine Receptor Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country (2018-2024)
10.4 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anavex Life Sciences Corp
11.1.1 Anavex Life Sciences Corp Company Detail
11.1.2 Anavex Life Sciences Corp Business Overview
11.1.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Introduction
11.1.4 Anavex Life Sciences Corp Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024)
11.1.5 Anavex Life Sciences Corp Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Detail
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor Introduction
11.2.4 AstraZeneca Plc Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024)
11.2.5 AstraZeneca Plc Recent Development
11.3 Heptares Therapeutics Ltd
11.3.1 Heptares Therapeutics Ltd Company Detail
11.3.2 Heptares Therapeutics Ltd Business Overview
11.3.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Introduction
11.3.4 Heptares Therapeutics Ltd Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024)
11.3.5 Heptares Therapeutics Ltd Recent Development
11.4 Karuna Pharmaceuticals Inc
11.4.1 Karuna Pharmaceuticals Inc Company Detail
11.4.2 Karuna Pharmaceuticals Inc Business Overview
11.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Introduction
11.4.4 Karuna Pharmaceuticals Inc Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024)
11.4.5 Karuna Pharmaceuticals Inc Recent Development
11.5 NeuroHealing Pharmaceuticals Inc
11.5.1 NeuroHealing Pharmaceuticals Inc Company Detail
11.5.2 NeuroHealing Pharmaceuticals Inc Business Overview
11.5.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Introduction
11.5.4 NeuroHealing Pharmaceuticals Inc Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024)
11.5.5 NeuroHealing Pharmaceuticals Inc Recent Development
11.6 Sumitomo Dainippon Pharma Co Ltd
11.6.1 Sumitomo Dainippon Pharma Co Ltd Company Detail
11.6.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
11.6.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Introduction
11.6.4 Sumitomo Dainippon Pharma Co Ltd Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024)
11.6.5 Sumitomo Dainippon Pharma Co Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Muscarinic Acetylcholine Receptor Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of M1
Table 3. Key Players of M4
Table 4. Key Players of M5
Table 5. Key Players of Others
Table 6. Global Muscarinic Acetylcholine Receptor Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Muscarinic Acetylcholine Receptor Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global Muscarinic Acetylcholine Receptor Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Muscarinic Acetylcholine Receptor Market Share by Region (2018-2024)
Table 10. Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Muscarinic Acetylcholine Receptor Market Share by Region (2024-2034)
Table 12. Muscarinic Acetylcholine Receptor Market Trends
Table 13. Muscarinic Acetylcholine Receptor Market Drivers
Table 14. Muscarinic Acetylcholine Receptor Market Challenges
Table 15. Muscarinic Acetylcholine Receptor Market Restraints
Table 16. Global Muscarinic Acetylcholine Receptor Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Muscarinic Acetylcholine Receptor Market Share by Players (2018-2024)
Table 18. Global Top Muscarinic Acetylcholine Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscarinic Acetylcholine Receptor as of 2022)
Table 19. Ranking of Global Top Muscarinic Acetylcholine Receptor Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Muscarinic Acetylcholine Receptor Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Muscarinic Acetylcholine Receptor Product Solution and Service
Table 23. Date of Enter into Muscarinic Acetylcholine Receptor Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Muscarinic Acetylcholine Receptor Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Type (2018-2024)
Table 27. Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Type (2024-2034)
Table 29. Global Muscarinic Acetylcholine Receptor Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Application (2018-2024)
Table 31. Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Application (2024-2034)
Table 33. North America Muscarinic Acetylcholine Receptor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 34. North America Muscarinic Acetylcholine Receptor Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Muscarinic Acetylcholine Receptor Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Muscarinic Acetylcholine Receptor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. Europe Muscarinic Acetylcholine Receptor Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Muscarinic Acetylcholine Receptor Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Muscarinic Acetylcholine Receptor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 43. Latin America Muscarinic Acetylcholine Receptor Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Muscarinic Acetylcholine Receptor Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 46. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country (2024-2034) & (US$ Million)
Table 48. Anavex Life Sciences Corp Company Detail
Table 49. Anavex Life Sciences Corp Business Overview
Table 50. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product
Table 51. Anavex Life Sciences Corp Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024) & (US$ Million)
Table 52. Anavex Life Sciences Corp Recent Development
Table 53. AstraZeneca Plc Company Detail
Table 54. AstraZeneca Plc Business Overview
Table 55. AstraZeneca Plc Muscarinic Acetylcholine Receptor Product
Table 56. AstraZeneca Plc Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024) & (US$ Million)
Table 57. AstraZeneca Plc Recent Development
Table 58. Heptares Therapeutics Ltd Company Detail
Table 59. Heptares Therapeutics Ltd Business Overview
Table 60. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product
Table 61. Heptares Therapeutics Ltd Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024) & (US$ Million)
Table 62. Heptares Therapeutics Ltd Recent Development
Table 63. Karuna Pharmaceuticals Inc Company Detail
Table 64. Karuna Pharmaceuticals Inc Business Overview
Table 65. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product
Table 66. Karuna Pharmaceuticals Inc Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024) & (US$ Million)
Table 67. Karuna Pharmaceuticals Inc Recent Development
Table 68. NeuroHealing Pharmaceuticals Inc Company Detail
Table 69. NeuroHealing Pharmaceuticals Inc Business Overview
Table 70. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product
Table 71. NeuroHealing Pharmaceuticals Inc Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024) & (US$ Million)
Table 72. NeuroHealing Pharmaceuticals Inc Recent Development
Table 73. Sumitomo Dainippon Pharma Co Ltd Company Detail
Table 74. Sumitomo Dainippon Pharma Co Ltd Business Overview
Table 75. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product
Table 76. Sumitomo Dainippon Pharma Co Ltd Revenue in Muscarinic Acetylcholine Receptor Business (2018-2024) & (US$ Million)
Table 77. Sumitomo Dainippon Pharma Co Ltd Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Muscarinic Acetylcholine Receptor Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Muscarinic Acetylcholine Receptor Market Share by Type: 2022 VS 2034
Figure 3. M1 Features
Figure 4. M4 Features
Figure 5. M5 Features
Figure 6. Others Features
Figure 7. Global Muscarinic Acetylcholine Receptor Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Muscarinic Acetylcholine Receptor Market Share by Application: 2022 VS 2034
Figure 9. Attention Deficit Hyperactivity Disorder Case Studies
Figure 10. Psychiatric Disorders Case Studies
Figure 11. Alzheimer's Disease Case Studies
Figure 12. Chronic Obstructive Pulmonary Disease Case Studies
Figure 13. Memory Impairment Case Studies
Figure 14. Muscarinic Acetylcholine Receptor Report Years Considered
Figure 15. Global Muscarinic Acetylcholine Receptor Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 16. Global Muscarinic Acetylcholine Receptor Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Muscarinic Acetylcholine Receptor Market Share by Region: 2022 VS 2034
Figure 18. Global Muscarinic Acetylcholine Receptor Market Share by Players in 2022
Figure 19. Global Top Muscarinic Acetylcholine Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscarinic Acetylcholine Receptor as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Muscarinic Acetylcholine Receptor Revenue in 2022
Figure 21. North America Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. North America Muscarinic Acetylcholine Receptor Market Share by Country (2018-2034)
Figure 23. United States Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Muscarinic Acetylcholine Receptor Market Share by Country (2018-2034)
Figure 27. Germany Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Muscarinic Acetylcholine Receptor Market Share by Region (2018-2034)
Figure 35. China Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Japan Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. South Korea Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Southeast Asia Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. India Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Australia Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Muscarinic Acetylcholine Receptor Market Share by Country (2018-2034)
Figure 43. Mexico Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Brazil Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Muscarinic Acetylcholine Receptor Market Share by Country (2018-2034)
Figure 47. Turkey Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Saudi Arabia Muscarinic Acetylcholine Receptor Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Anavex Life Sciences Corp Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2018-2024)
Figure 50. AstraZeneca Plc Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2018-2024)
Figure 51. Heptares Therapeutics Ltd Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2018-2024)
Figure 52. Karuna Pharmaceuticals Inc Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2018-2024)
Figure 53. NeuroHealing Pharmaceuticals Inc Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2018-2024)
Figure 54. Sumitomo Dainippon Pharma Co Ltd Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed